
Chronic toxicity in zebrafish refers to the assessment of adverse effects caused by prolonged or continuous exposure to a test substance over a significant portion of the organism's lifespan typically ≥ 28 days to a full life cycle.
These studies aim to identify the lowest concentration at which toxic effects occur (LOEC) and the highest concentration at which no adverse effects are observed (NOEC), providing critical data for environmental risk assessment and regulatory decision-making.
Study period: Typically ranges from 30 days to several months. Early-life stage studies: ~30–60 days. Adult studies: ≥ 90 days. Life-cycle studies: up to 6 months or more.
OECD test guidelines governing subacute toxicity studies across oral, dermal, and inhalation routes of administration.
Early-Life Stage
FSTRA
Screening Assay for Endocrine Active Substances
FSDT
Controlled long-term aqueous exposure to multiple concentrations of a test substance.
Evaluation of survival, growth, development, reproduction, and other chronic toxic effects.
Determination of concentration-response relationships and chronic toxicity endpoints such as NOEC, LOEC, ECx, and MATC.
Each subacute toxicity study is designed to achieve specific scientific and regulatory objectives.
Standardized zebrafish models are selected based on regulatory acceptability and biological relevance.
Controlled housing conditions are maintained throughout the study to minimize variability and ensure animal welfare compliance.
The route of administration is selected based on the intended use of the test substance and the applicable OECD guideline.
Aqueous Exposure
The test substance is dissolved or dispersed in water, allowing continuous uptake by zebrafish through the gills, skin, and other exposed tissues.
Sub-Acute toxicity studies are essential for determining the safety profile of a wide range of products before clinical use or regulatory approval.